Barinthus Biotherapeutics (BRNS) Receivables - Other (2020 - 2026)
Barinthus Biotherapeutics (BRNS) reported Receivables - Other of $1.28 million for Q2 2026, down 71.8% from $4.54 million a year earlier but up 4.0% from the prior quarter.
Powered by 
Analysis
Barinthus Biotherapeutics (BRNS) Receivables - Other (2020 - 2026) Analysis & Trends
At the end of FY2025, Barinthus Biotherapeutics posted Receivables - Other of $1.11 million, down 84.5% from FY2024.
- Receivables - Other has a five-year compound annual growth rate of -16.4% (FY2020 to FY2025).
- By year, Receivables - Other came in at $7.14 million in FY2024 (+45.5%), $4.91 million in FY2023 (-10.8%), $5.5 million in FY2022 (-11.7%) and $6.23 million in FY2021 (+130.0%).
- Five-year quarterly Receivables - Other spans a low of $1.11 million in Q4 2025 and a high of $17.05 million in Q2 2022.
- Year over year, Receivables - Other has now declined in each of the last four quarters, with an average decline of 2.7% over the last eight quarters.
- The high point for year-over-year Receivables - Other in five years was Q2 2022 (growth of 274.0%); the low point was Q4 2025 (a decline of 84.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.23 million (Q1 2026), $1.11 million (Q4 2025) and $4.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Barinthus Biotherapeutics | 30.23 Mn | 30.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.28 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 4.63 Mn |
| Jun 30, 2025 | 4.54 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 7.14 Mn |
| Sep 30, 2024 | 14.97 Mn |
| Jun 30, 2024 | 4.52 Mn |
| Mar 31, 2024 | 5.20 Mn |
| Dec 31, 2023 | 4.91 Mn |
| Sep 30, 2023 | 4.17 Mn |
| Jun 30, 2023 | 3.14 Mn |
| Mar 31, 2023 | 2.50 Mn |
| Dec 31, 2022 | 4.54 Mn |
| Sep 30, 2022 | 6.15 Mn |
| Jun 30, 2022 | 17.05 Mn |
| Mar 31, 2022 | 4.78 Mn |
| Dec 31, 2021 | 6.23 Mn |
| Sep 30, 2021 | 5.38 Mn |
API Access
Barinthus Biotherapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=BRNS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "BRNS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=BRNS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();